 |
| Edward Nardell, MD |
Edward Nardell, MD, of the Division of Pulmonary and Critical Care Medicine and the Division of Global Health Equity, received the Karel Styblo Public Health Prize from The International Union Against Tuberculosis and Lung Disease (The Union) in recognition of his extraordinary contributions to public health. This award acknowledges a health worker or a community organization for contributions to tuberculosis (TB) control over a period of 10 years or more. Nardell is the first U.S.-born recipient of the award, which established in 1997.
The Karel Styblo Public Health Prize is named in memory of Karel Styblo, MD, an internationally renowned TB expert who served as director of Scientific Activities at The Union from 1979 to 1991 and who played a central role in developing a TB control model later named Directly Observed Treatment, Short Course (DOTS) by the World Health Organization. In his early years attending the annual Union meetings, Nardell had the privilege of knowing Dr. Styblo.
Nardell is a prominent researcher of multidrug resistant tuberculosis (MDR-TB), with a focus on airborne TB transmission and control. He was the principal investigator of a five-year Fogarty Innovation Grant that uses new technological approaches to airborne infection control. At the Harvard T.H. Chan School of Public Health, he developed an annual course to train architects, engineers and physicians from around the world to build safer buildings in high-burden countries. He is actively developing more efficient and inexpensive ultraviolet germicidal irradiation fixtures, now in great demand for airborne SARS-CoV-2 control as well as TB.
The Union is a global scientific organization working to improve health for people in low- and middle-income countries by conducting scientific research, working with governments and other agencies to translate research into better health for people around the world, and delivering projects directly in the field, driving change to ensure the best-quality care.
